CA2449450A1 - Technique et compositions de traitement du cancer - Google Patents

Technique et compositions de traitement du cancer Download PDF

Info

Publication number
CA2449450A1
CA2449450A1 CA002449450A CA2449450A CA2449450A1 CA 2449450 A1 CA2449450 A1 CA 2449450A1 CA 002449450 A CA002449450 A CA 002449450A CA 2449450 A CA2449450 A CA 2449450A CA 2449450 A1 CA2449450 A1 CA 2449450A1
Authority
CA
Canada
Prior art keywords
treatment
compound
cancer
phorbol
gingerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002449450A
Other languages
English (en)
Inventor
Zigang Dong
Ann M. Bode
Wei-Ya Ma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2449450A1 publication Critical patent/CA2449450A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des compositions pharmaceutiques comprenant: une combinaison d'un composé représenté par la formule (I) dans laquelle R?1¿ est C¿1?-C¿6? alkyle et R?2¿ est indépendamment -H or OH ou un sel de ceux-ci répondant aux normes pharmaceutiques et un composé phorbol. Cette invention concerne aussi d'autres compositions ainsi que les utilisations de toutes ces compositions dans le traitement de cancers ou de tumeurs établis.
CA002449450A 2001-06-05 2002-06-04 Technique et compositions de traitement du cancer Abandoned CA2449450A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29609801P 2001-06-05 2001-06-05
US60/296,098 2001-06-05
PCT/US2002/017705 WO2002098399A2 (fr) 2001-06-05 2002-06-04 Technique et compositions de traitement du cancer

Publications (1)

Publication Number Publication Date
CA2449450A1 true CA2449450A1 (fr) 2002-12-12

Family

ID=23140595

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002449450A Abandoned CA2449450A1 (fr) 2001-06-05 2002-06-04 Technique et compositions de traitement du cancer

Country Status (4)

Country Link
EP (1) EP1392266A2 (fr)
AU (1) AU2002305823A1 (fr)
CA (1) CA2449450A1 (fr)
WO (1) WO2002098399A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2411229C2 (ru) * 2004-09-23 2011-02-10 Учреждение Российской академии наук Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН (ТИБОХ ДВО РАН) Терапевтические хиноны
US20080181877A1 (en) * 2006-03-22 2008-07-31 Leangene Ab, C/O Cit Ekonomiservice Ab Method For Monitoring the Effect of Compounds on Foxc2 Expression
FR2950884B1 (fr) * 2009-10-01 2011-11-11 Oreal Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition
CN103222986A (zh) * 2012-01-31 2013-07-31 岳旺 姜辣素与代赭石组合物在制备癌症化疗中减毒增效药物中的用途
KR101547735B1 (ko) 2013-12-09 2015-08-26 가천대학교 산학협력단 파라돌을 포함하는 뇌손상 예방 또는 치료용 조성물
KR20240065168A (ko) * 2015-12-10 2024-05-14 시므라이즈 아게 안정화된 맛 및 냄새를 갖는 조성물
US20210244820A1 (en) * 2018-06-15 2021-08-12 Neonc Technologies, Inc. Pharmaceutical compositions comprising poh derivatives

Also Published As

Publication number Publication date
WO2002098399A2 (fr) 2002-12-12
WO2002098399A3 (fr) 2003-02-27
EP1392266A2 (fr) 2004-03-03
AU2002305823A1 (en) 2002-12-16

Similar Documents

Publication Publication Date Title
US7410656B2 (en) Anti-cancer compounds
US5945106A (en) Montoxic extract of Larrea tridentata and method of making the same
US20030105031A1 (en) Methods for the treatment of skin disorders
US20120258060A1 (en) Methods for protecting the skin from radiation insults
US9956257B2 (en) Canola extracts containing high levels of phenolic acids
JP5440985B2 (ja) メラノーマの治療
WO2006009893A2 (fr) Chimiotherapie anticancereuse
US20040156799A1 (en) Cancer treatment method and compositions
US20090239943A1 (en) Nutraceutical composition and methods for its use
JP2004516257A (ja) 糖尿病性神経障害の治療に対する組成物及びその方法
US20020001573A1 (en) Immunostimulator anti-cancer compounds
CA2449450A1 (fr) Technique et compositions de traitement du cancer
US20080118589A1 (en) Pharmaceutical formulations of rhodiola crenulata and methods of use thereof
WO2014183055A1 (fr) Méthodes permettant de traiter des affections cutanées au moyen de composés de cyclolignans
Sekhar et al. A review on anticancer potential of natural drugs: hispolon and limonene
JP2003171349A (ja) 新規なジテルペン類、及びこれを用いた組成物、抗炎症剤、抗癌剤
AU748545B2 (en) Anti-cancer compounds-III
WO2011044587A2 (fr) Composition végétale cytoprotectrice ou thérapeutique
AU750628B2 (en) Anti-cancer compounds-II
JP2005528441A (ja) 運動性能及び／又は持久力を増強するための方法
Pinto et al. Insight Approaches of Medicinal Plants for the Discovery of Anticancer Drugs
LV15503B (lv) 2h-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā
AU4811601A (en) Anti-cancer compounds-I
Grady The effect of resveratrol on ultraviolet light-induced skin cell death

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20080604